Janux Therapeutics (JANX) Earnings Date & Reports

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JANX is expected to report earnings to rise 1.94% to -36 cents per share on May 13

Janux Therapeutics JANX Stock Earnings Reports

Q1'25

Est.

$-0.37

Q4'24

Beat

by $0.07

Q3'24

Missed

by $0.18

Q2'24

Beat

by $0.20

Q1'24

Beat

by $0.04

The last earnings report on February 27 showed earnings per share of -36 cents, beating the estimate of -42 cents. With 685.22K shares outstanding, the current market capitalization sits at 1.90B.

View a ticker or compare two or three

Compare

JANX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For JANX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for JANX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

10955 Vista Sorrento Parkway

Phone

+1 858 751-4493

Employees

Web

https://www.januxrx.com